AJR Live Webinars feature leading experts discussing some of AJR’s most controversial, cutting-edge articles—broadcasted each month live, online, with CME.

Miss a broadcast? You can still watch past webinars and earn credit.

Past AJR Live Webinars

The AJR Live Webinar Series was made possible in part by an unrestricted educational grant from Siemens Healthcare.

Upcoming Webinars

Borderline Resectable and Locally Advanced Pancreas Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Neoadjuvant Therapy Pathologic Response and Prediction of Survival

July 21, 2021

Broadcasted Live and Online 12:00 noon–1:00 pm, Eastern Time 
Moderator: Heather Jacene, MD
Speakers: Ajit H. Goenka, MD, & Mark J. Truty, MD, MS

REGISTER NOW

This AJR Live Webinar offers 1 CME Credit.

ARRS Member Price: $0

ARRS In-Training Member Price: $0 
Nonmember Price: $99

This webinar will discuss the imaging metrics from integrated FDG- PET/MRI for guiding clinical management and outcomes such as pathologic response and overall survival in patients with pancreatic ductal adenocarcinoma (PDA) receiving emergent therapeutic interventions.

Learning Outcomes

After attending this session, participants will be able to:

  • Discuss how metabolic metrics from PET/MRI can assess pathologic response to NAT as well as predict survival.
  • Articulate how the widely used serum biomarker CA 19-9, either in terms of the baseline value or in terms of normalization after NAT, is not associated with pathologic response or survival.

Updates and Ongoing Challenges in Imaging of Multiple Myeloma

August 18, 2021

Broadcasted Live and Online 12:00 noon–1:00 pm, Eastern Time 
Moderator: Eric Y. Chang, MD
Speakers: Fangbai Wu, MD

REGISTER NOW

This AJR Live Webinar offers 1 CME Credit.

ARRS Member Price: $0

ARRS In-Training Member Price: $0 
Nonmember Price: $99

In this webinar we will discuss the recently revised imaging recommendations of the International Myeloma Working Group for different disease stages, focusing on the use of advanced whole-body imaging modalities. Ongoing challenges and controversies will be reviewed, and consensus opinions will be offered regarding the role of imaging in multiple myeloma for characterization of disease distribution, determination of prognosis, and response evaluation.

Learning Outcomes

After attending this session, participants will be able to:

  • List the different stages of multiple myeloma.
  • Discuss the rationale for whole-body low-dose CT for initial patient assessment.
  • Describe the roles of whole-body MRI and FDG PET/CT in multiple myeloma.

The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.

The ARRS designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.